Multi-arm Clinical Trials – Teams within Teams - Clinical Oncology
IMerge Study Myelodysplastic Syndromes Clinical Trial | Imetelstat | Geron
Clinical Trial Design: Parallel and Crossover Studies | Lilly Trials Blog
Clinical Trials - Study Background | Aliqopa US HCP
Phase III randomized, clinical trial of 5 different arms of treatment... | Download Scientific Diagram
Clinical trials are better, faster, cheaper with big data | MIT Technology Review
arm - Clinical Research Glossary
A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis - Value in Health
Program in Regulatory Science Clinical Trial Designs - Dana-Farber Cancer Institute | Boston, MA
Multi-Arm Multi-Stage - EUPATI Toolbox
New approaches to clinical trials: Adaptive designs - EUPATI Toolbox
Phase III randomized, clinical trial of 5 different arms of treatment... | Download Scientific Diagram
Can Synthetic Control Arms Address Regulatory and HTA Evidence Requirements?
The use of telerehabilitation for patients with Parkinson's disease: A three-arm pilot randomized clinical trial protocol | LeaRRn
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial - The Lancet Infectious Diseases
Designs for adding a treatment arm to an ongoing clinical trial | Trials | Full Text
A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. | Semantic Scholar
Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice | Trials | Full Text
Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials - ScienceDirect
The I-SPY2 Trial
Synthetic Control Arm in Clinical Trials | CenterWatch
On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control
An overview of platform trials with a checklist for clinical readers - Journal of Clinical Epidemiology
Optimizing Clinical Trial Design in Rare Diseases - Blue Matter Consulting
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols | Trials | Full Text
Historical clinical trials data can reduce the need for control arm patients | Medidata Solutions - Medidata Solutions
